NanoEcho and us4us have signed a letter of intent
NanoEcho has chosen the supplier us4us and started collaboration around the development and future manufacturing of the imaging device. NanoEcho and us4us have signed a letter of intent and agreed to collaborate regarding the development of NanoEcho’s imaging device, specifically the ultrasound scanner unit. The imaging device is aimed to be used at medical hospitals, as support […]
A new Board has been appointed at NanoEcho – increased focus on commercialization
A new Board that reflects the Company’s development has been appointed. The newly appointed Chairman is Daniel Johnsson, former CEO and founder of, among others, Exertis Nordics, now investor and advisor. A new member of the Company’s Board is PhD and Business Coach Ann-Christin Malmborg Hager. At the Annual General Meeting, NanoEcho elected Daniel Johnsson […]
NanoEcho takes the next step and enters a detailed product development phase
NanoEcho has conducted a “Design Input Review” – a systematic review of collected requirements and development plans for the product development phase. The company now enters a detailed design development phase with the objective of developing a prototype prepared for commercialization. The result of the conducted review is that all requirements; clinical, regulatory, technical and […]
NanoEcho has chosen supplier of ultrasound transducer
NanoEcho has chosen the supplier Vermon SA, and started cooperation for the development and future manufacturing of the ultrasound transducer. As an important step in NanoEchos work, to design and produce a product for commercial use, NanoEcho will collaborate with Vermon in the development of the ultrasound transducer. NanoEcho and Vermon have signed a Letter […]
New shareholders after previous main owner has sold its holdings
NanoEcho welcomes new shareholders when one of the company’s previous main owners, Cardeon AB, has sold its holdings in the company. NanoEcho’s CEO Linda Persson has actively participated in the process through several national and international presentations to potential investors and has also been available for discussions and questions. The sales process has been handled […]
Basic patent granted in Europe and South Korea
NanoEcho’s innovative method aims to address an urgent global need for more reliable rectal cancer staging. The method is intended to enable the mapping of lymphatic cancer spread prior to surgery – an important marker for the cancer’s progression. This mapping would make it possible to avoid surgery with high risk of complications. The basic […]
A historic day – for the first time ever, a magnetomotive ultrasound was applied to human tissue
Yesterday was a historic day for NanoEcho. To our knowledge, this is the first time ever that the magnetomotive ultrasound method has been applied to human tissue. This was carried out on operated cancer tissue using NanoEcho’s first generation portable system at Sahlgrenska University Hospital in Gothenburg. Our system is designed to map, with high […]
Basic patent granted in Japan
The basic patent for NanoEcho’s method has now been granted in Japan. We have also received positive feedback on the same patent in Europe from the European Patent Office, which has announced that it intends to grant the patent. The same patent is also under review in Canada and the US, where the process is […]
First patient recruited in clinical trial on surgically removed tissue
NanoEcho has been given the go-ahead to begin clinical trials on surgically removed rectal cancer tissue at Sahlgrenska University Hospital in Gothenburg and at Skåne University Hospital in Malmö. The first patient has now been recruited at Sahlgrenska University Hospital. NanoEcho is developing a new medical imaging technique for the diagnosis of rectal cancer. The […]
Ethics application approved for preclinical study at Skåne University Hospital
NanoEcho will conduct a preclinical study led by Henrik Thorlacius, Professor of Surgery at Lund University and Chief Physician at Skåne University Hospital in Malmö, in which NanoEcho’s new instrument for detection of lymph nodes with cancer spread will be evaluated. The study will be carried out at Skåne University Hospital in Malmö and will […]
